RANZCP homepage
Clinical guidelines & publications library
-
Consultation on the special authority criteria for the class B stimulants
ADHD
Submission to Pharmac regarding the special authority criteria for the class B stimulants prescriptions in Aotearoa.
PDF SubmissionSubmission- Last updated: Jun 2023
- Published in New Zealand
- Current
-
Consultation on methylphenidate to include early access to the Ritalin LA preparations
ADHD
Submission to Pharmac regarding consultation on methylphenidate to include early access to the Ritalin LA preparations. PDF Submission
Submission- Last updated: Jun 2023
- Published in New Zealand
- Current
-
Adult attention deficit hyperactivity disorder (ADHD) practice guidelines
ADHD, Professionalism
This guideline was rescinded in April 2024.
Clinical guideline- Last updated: Apr 2024
- Published in Australia
- Rescinded
-
ADHD across the lifespan
ADHD, Culturally safe practice, Professionalism
Attention Deficit Hyperactivity Disorder (ADHD) is a major mental disorder. This statement presents principles to develop a more appropriate, accessible, equitable health system that caters for the needs of people with ADHD across their lifespan.
Position statement- Last updated: Mar 2023
- Published in Australia
- PS #55
